MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jns.2024.123352

Медицинская библиотека · Journal of the neurological sciences · 2024

Antithrombotic therapy for secondary Stroke prevention in patients with symptomatic large artery atherosclerosis and atrial fibrillation (FIB-CAS study) A single-center experience.

Mohamed Ghada A, Qdais Ahmad Abu, Hanna Mckay, Myesrlis Evangelos Pavlos, Zulfiqar Maryam, Turan Tanya N

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Atrial fibrillation (AF) and large artery atherosclerotic diseases are major causes of ischemic stroke and their coexistence increases the risk of stroke and mortality. Research on antithrombotic strategies for AF patients with symptomatic large artery atherosclerosis is limited. This study aims to report a single center's experience regarding the antithrombotic regimens prescribed for this population and the association with stroke recurrence and hemorrhagic events.

METHODOLOGY: This retrospective cohort study included AF patients admitted to the Medical University of South Carolina with stroke due to symptomatic intracranial (sICAS) or extracranial atherosclerosis (sECAS). Patients were grouped based on prescribed antithrombotic regimens and compared according to their outcomes.

RESULTS

Of 1,924 ischemic stroke patients with AF, 114 (6%) met the inclusion criteria. At discharge, the majority of patients were prescribed anticoagulants alone (sAC) or combined with a single antiplatelet (sAC + sAP) 26% and 34% respectively. Stroke recurrence was highest during the first 90-days after index stroke (11%). Patients on combination sAC + sAP had fewer recurrent strokes in the first 90-days compared to sAC (5.5% vs. 22.2%,p = 0.056) without significant increase in symptomatic hemorrhagic events (5.5% vs. 3.7%, p = 0.6). However the hemorrhagic risk significantly increased with prolonged therapy beyond 90-days (18% vs. 0%,p = <0.02). Early deaths were also high with 37% of total deaths occurring within 90-days after index stroke.

CONCLUSION

In this cohort, AF patients with stroke due to sICAS or sECAS had early stroke recurrence and mortality. While combination AC + sAP may reduce short-term stroke recurrence they may increase the hemorrhagic risk in the long-term.

Для цитирования: Mohamed Ghada A, Qdais Ahmad Abu, Hanna Mckay, Myesrlis Evangelos Pavlos, Zulfiqar Maryam, Turan Tanya N. Antithrombotic therapy for secondary Stroke prevention in patients with symptomatic large artery atherosclerosis and atrial fibrillation (FIB-CAS study) A single-center experience.. Journal of the neurological sciences. 2024. DOI: 10.1016/j.jns.2024.123352.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.